Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19. Rappaport SH, Clark JM, Delibert S, Maynard KM, et al. Am J Respir Crit Care Med 2020 Sep 15. doi: 10.1164/rccm.202006-2511.

Read + Share

Amedeo Smart

Independent Medical Education

Rappaport SH, Clark JM, Delibert S, Maynard KM, et al. Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19. Am J Respir Crit Care Med 2020 Sep 15. doi: 10.1164/rccm.202006-2511.
PMID: 32931713